Heiner Wedemeyer is a full professor and Head and Chair of the Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology at Hannover Medical School, Hannover, Germany. Professor Wedemeyer’s main interests are the immunopathogenesis of HBV, HCV, HDV, and HEV infections, as well as the development of novel immunomodulatory therapies, the hepatological treatment of acute and chronic liver diseases and the treatment of liver cancer that can lead to liver transplantation. He has been Principal Investigator on several Phase 1–4 clinical trials on antivirals and immunotherapies in viral hepatitis. Professor Wedemeyer has been involved in the scientific coordination of the German Network of Competence on Viral Hepatitis (Hep-Net) since 2002, and the German Liver Foundation since 2006. He was the EASL Secretary General from 2009–2011 and a member of the United European Gastroenterology Scientific Committee from 2013–2016. Heiner Wedemeyer is spokesperson of the “D-SOLVE” consortium funded by the European Union and since January 2023 he is President of the German Society for Digestive and Metabolic Diseases (DGVS).
Professor Wedemeyer has authored more than 560 original articles in international peer-reviewed journals, including several national and international guidelines on the management of HBV, HCV, HDV and hepatocellular carcinoma.
